Calming And Sleeping Products in Germany
Euromonitor International's Calming And Sleeping Products in Germany market report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, packaging innovations, economic/lifestyle influences, distribution or pricing issues. Forecasts illustrate how the market is set to change.
Buy online to access strategic market analysis and an interactive statistical database of volume and value market sizes, company and brand shares, distribution and pricing data.
Tables: 41 | Publication date: Jul 2008
Why buy this report
- Get insight into trends in market performance
- Pinpoint growth sectors and identify factors driving change
- Identify market and brand leaders and understand the competitive environment
Table of contents
OTC HEALTHCARE IN GERMANY : MARKET INSIGHT
EXECUTIVE SUMMARY
Stagnating sales
Ageing population requires more medical care
Distribution system under fire
Market concentration continues
KEY TRENDS AND DEVELOPMENTS
German consumers: older, but working longer and playing harder
German consumers ever more health aware
German distribution system shake up
Rx-to-OTC switches
Market concentration continues
MARKET INDICATORS
Table 1 Consumer Expenditure on Health Goods and Medical Services 2002-2007
Table 2 Life Expectancy at Birth 2002-2007
MARKET DATA
Table 3 Sales of OTC Healthcare by Sector: Value 2002-2007
Table 4 Sales of OTC Healthcare by Sector: % Value Growth 2002-2007
Table 5 OTC Healthcare Company Shares by Value 2003-2007
Table 6 OTC Healthcare Brand Shares by Value 2004-2007
Table 7 Penetration of Private Label by Sector 2003-2007
Table 8 Sales of OTC Healthcare by Distribution Format: % Analysis 2002-2007
Table 9 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2007
Table 10 Forecast Sales of OTC Healthcare by Sector: Value 2007-2012
Table 11 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2007-2012
APPENDIX
OTC Registration and Classification
Vitamins and dietary supplements registration and classification
Generics
Consumer expenditure on health goods and medical services
DEFINITIONS
Sources
Summary 1 Research Sources
LOCAL COMPANY PROFILES - GERMANY
BAYER HEALTHCARE AG - OTC HEALTHCARE - GERMANY
STRATEGIC DIRECTION
KEY FACTS
Summary 2 Bayer HealthCare AG: Key Facts
Summary 3 Bayer HealthCare AG: Operational Indicators (Global)
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 4 Bayer Healthcare AG: Competitive Position 2007
BEIERSDORF AG - OTC HEALTHCARE - GERMANY
STRATEGIC DIRECTION
KEY FACTS
Summary 5 Beiersdorf AG: Key Facts
Summary 6 Beiersdorf AG: Operational Indicators (Global)
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 7 Beiersdorf AG: Competitive Position 2007
BOEHRINGER INGELHEIM PHARMA GMBH & CO KG - OTC HEALTHCARE - GERMANY
STRATEGIC DIRECTION
KEY FACTS
Summary 8 Boehringer Ingelheim Pharma GmbH & Co KG: Key Facts
Summary 9 Boehringer Ingelheim Pharma GmbH & Co KG: Operational Indicators (Global)
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 10 Boehringer Ingelheim Pharma GmbH & Co KG: Competitive Position 2007
JOHNSON & JOHNSON GMBH - OTC HEALTHCARE - GERMANY
STRATEGIC DIRECTION
KEY FACTS
Summary 11 Johnson & Johnson GmbH: Key Facts
Summary 12 Johnson & Johnson GmbH: Operational Indicators (Global)
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 13 Johnson & Johnson GmbH: Competitive Position 2007
MCM KLOSTERFRAU VERTRIEBSGESELLSCHAFT MBH - OTC HEALTHCARE - GERMANY
STRATEGIC DIRECTION
KEY FACTS
Summary 14 MCM Klosterfrau Vertriebsgesellschaft mbH: Key Facts
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 15 MCM Klosterfrau Vertriebsgesellschaft mbH: Competitive Position 2007
NOVARTIS DEUTSCHLAND GMBH - OTC HEALTHCARE - GERMANY
STRATEGIC DIRECTION
KEY FACTS
Summary 16 Novartis Deutschland GmbH: Key Facts
Summary 17 Novartis Deutschland GmbH: Operational Indicators (Global)
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 18 Novartis Consumer Health GmbH: Competitive Position 2007
RATIOPHARM GMBH & CO - OTC HEALTHCARE - GERMANY
STRATEGIC DIRECTION
KEY FACTS
Summary 19 Ratiopharm GmbH & Co: Key Facts
Summary 20 Ratiopharm GmbH & Co: Operational Indicators (Global)
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 21 Ratiopharm GmbH & Co: Competitive Position 2007
STADA ARZNEIMITTEL AG - OTC HEALTHCARE - GERMANY
STRATEGIC DIRECTION
KEY FACTS
Summary 22 STADA Arzneimittel AG: Key Facts
Summary 23 STADA Arzneimittel AG: Operational Indicators (Global)
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 24 STADA Arzneimittel AG: Competitive Position 2007
CALMING AND SLEEPING PRODUCTS IN GERMANY
OVERVIEW
SECTOR DATA
Table 12 Sales of Calming and Sleeping Products: Value 2002-2007
Table 13 Sales of Calming and Sleeping Products: % Value Growth 2002-2007
Table 14 Calming and Sleeping Products Company Shares by Value 2003-2007
Table 15 Calming and Sleeping Products Brand Shares by Value 2004-2007
Table 16 Forecast Sales of Calming and Sleeping Products: Value 2007-2012
Table 17 Forecast Sales of Calming and Sleeping Products: % Value Growth 2007-2012